{
    "version": "https://jsonfeed.org/version/1.1",
    "title": "Harvard Health Posts by Pushpa Narayanaswami, MD, FAAN Feed",
    "home_page_url": "https://www.health.harvard.edu/authors/pushpa-narayanaswami-md-faan",
    "feed_url": "https://www.health.harvard.edu/authors/pushpa-narayanaswami-md-faan/feed/json",
    "language": "en-US",
    "icon": "https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg",
    "items": [{
            "id": "https://www.health.harvard.edu/blog/how-is-treatment-for-myasthenia-gravis-evolving-2021041222358",
            "title": "How is treatment for myasthenia gravis evolving?",
            "url": "https://www.health.harvard.edu/blog/how-is-treatment-for-myasthenia-gravis-evolving-2021041222358",
            "content_html": "Myasthenia gravis (MG) is a rare neuromuscular disease that impairs the transmission of nerve signals to muscles, causing temporary weakness of affected muscles. While treatment is complex, recently updated guidelines have added to the understanding of MG and are improving approaches to treatment.",
            "summary": "Myasthenia gravis (MG) is a rare neuromuscular disease that impairs the transmission of nerve signals to muscles, causing temporary weakness of affected muscles. While treatment is complex, recently updated guidelines have added to the understanding of MG and are improving approaches to treatment.",
            "date_published": "2021-04-12T14:30:10-04:00",
            "date_modified": "2021-04-12T14:30:10-04:00",
                        "authors": [                { "name": "Pushpa Narayanaswami, MD, FAAN" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/10476/conversions/GettyImages-1217908836-thumb.jpg",

            "tags": [ "Brain health","Autoimmune diseases" ]
        }        
    ]
}